Market Research Logo

Benitec Biopharma Ltd (BLT) - Financial and Strategic SWOT Analysis Review

Benitec Biopharma Ltd (BLT) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Benitec Biopharma Ltd (Benitec) is a clinical stage biotechnology company. The company develops novel therapeutics for the treatment of chronic and life threatening diseases based on its proprietary gene silencing DNA directed RNA interference (ddRNAi) technology. It develops ddRNAi based therapeutics for various conditions such as hepatitis B, wet age-related macular degeneration and OPMD. The company also licenses ddRNAi to various biopharmaceutical companies for the development of drugs. The company has research laboratories in Hayward, California, the US. Benitec is headquartered in Sydney, New South Wales, Australia.

Benitec Biopharma Ltd Key Recent Developments

Sep 19,2018: Benitec Biopharma names Gregory R. Reyes as senior scientific advisor
Jul 10,2018: Axovant and Benitec estbalish gene therapy partnership
May 31,2018: Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update
May 31,2018: Benitec Biopharma: Interim Report for the nine months ended March 31, 2018
Feb 22,2018: Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Benitec Biopharma Ltd - Key Facts
Benitec Biopharma Ltd - Key Employees
Benitec Biopharma Ltd - Key Employee Biographies
Benitec Biopharma Ltd - Major Products and Services
Benitec Biopharma Ltd - History
Benitec Biopharma Ltd - Company Statement
Benitec Biopharma Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Benitec Biopharma Ltd - Business Description
Benitec Biopharma Ltd - Corporate Strategy
Benitec Biopharma Ltd - SWOT Analysis
SWOT Analysis - Overview
Benitec Biopharma Ltd - Strengths
Benitec Biopharma Ltd - Weaknesses
Benitec Biopharma Ltd - Opportunities
Benitec Biopharma Ltd - Threats
Benitec Biopharma Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Benitec Biopharma Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 10, 2018: Axovant and Benitec estbalish gene therapy partnership
May 31, 2018: Benitec Biopharma reports financial results for the 2018 fiscal third quarter and provides operational update
May 31, 2018: Benitec Biopharma: Interim Report for the nine months ended March 31, 2018
Feb 22, 2018: Benitec Biopharma reports financial results for the 2018 fiscal second quarter and provides operational update
Nov 29, 2017: Benitec Biopharma reports financial results for the 2018 fiscal first quarter and provides operational update
Oct 23, 2017: Benitec announces resignation of Director, Dr John Chiplin
Oct 18, 2017: U.S. patent granted for Benitec hepatitis B program
Oct 12, 2017: Benitec announces the appointment of a new Chairman
Oct 10, 2017: Benitec announces resignation of Chief Business and Operations Officer
Sep 25, 2017: BioPharma Services Completes its 1st Year of a 5 Year Phase 1 Program with the US FDA
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Benitec Biopharma Ltd, Key Facts
Benitec Biopharma Ltd, Key Employees
Benitec Biopharma Ltd, Key Employee Biographies
Benitec Biopharma Ltd, Major Products and Services
Benitec Biopharma Ltd, History
Benitec Biopharma Ltd, Other Locations
Benitec Biopharma Ltd, Subsidiaries
Benitec Biopharma Ltd, Key Competitors
Benitec Biopharma Ltd, Ratios based on current share price
Benitec Biopharma Ltd, Annual Ratios
Benitec Biopharma Ltd, Annual Ratios (Cont...1)
Benitec Biopharma Ltd, Interim Ratios
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Benitec Biopharma Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Benitec Biopharma Ltd, Performance Chart (2014 - 2018)
Benitec Biopharma Ltd, Ratio Charts
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Benitec Biopharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report